ZA200607427B - Treatment of impaired respiratory function with gaboxadol - Google Patents
Treatment of impaired respiratory function with gaboxadolInfo
- Publication number
- ZA200607427B ZA200607427B ZA200607427A ZA200607427A ZA200607427B ZA 200607427 B ZA200607427 B ZA 200607427B ZA 200607427 A ZA200607427 A ZA 200607427A ZA 200607427 A ZA200607427 A ZA 200607427A ZA 200607427 B ZA200607427 B ZA 200607427B
- Authority
- ZA
- South Africa
- Prior art keywords
- gaboxadol
- treatment
- respiratory function
- impaired respiratory
- impaired
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200400540 | 2004-04-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200607427B true ZA200607427B (en) | 2009-02-25 |
Family
ID=36608890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200607427A ZA200607427B (en) | 2004-04-02 | 2005-03-31 | Treatment of impaired respiratory function with gaboxadol |
Country Status (6)
Country | Link |
---|---|
KR (1) | KR20070010136A (en) |
CN (1) | CN1942185A (en) |
AR (1) | AR048460A1 (en) |
EA (1) | EA200601853A1 (en) |
IL (1) | IL178289A0 (en) |
ZA (1) | ZA200607427B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11123332B2 (en) | 2018-11-21 | 2021-09-21 | Certego Therapeutics Inc. | Gaboxadol for reducing risk of suicide and rapid relief of depression |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017015049A1 (en) * | 2015-07-17 | 2017-01-26 | Ovid Therapeutics Inc. | Methods of treating developmental disorders with gaboxadol |
MX2020001342A (en) * | 2017-08-04 | 2020-08-31 | Ovid Therapeutics Inc | Use of gaboxadol in the treatment of diabetes and related conditions. |
-
2005
- 2005-03-31 CN CNA2005800119819A patent/CN1942185A/en active Pending
- 2005-03-31 KR KR1020067019852A patent/KR20070010136A/en not_active Application Discontinuation
- 2005-03-31 ZA ZA200607427A patent/ZA200607427B/en unknown
- 2005-03-31 EA EA200601853A patent/EA200601853A1/en unknown
- 2005-04-01 AR ARP050101300A patent/AR048460A1/en unknown
-
2006
- 2006-09-25 IL IL178289A patent/IL178289A0/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11123332B2 (en) | 2018-11-21 | 2021-09-21 | Certego Therapeutics Inc. | Gaboxadol for reducing risk of suicide and rapid relief of depression |
Also Published As
Publication number | Publication date |
---|---|
EA200601853A1 (en) | 2007-02-27 |
AR048460A1 (en) | 2006-04-26 |
KR20070010136A (en) | 2007-01-22 |
IL178289A0 (en) | 2007-03-08 |
CN1942185A (en) | 2007-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200705402B (en) | Respiratory devices and methods of use | |
IL178996A0 (en) | Thienopyridinone compounds and methods of treatment | |
EP1755584A4 (en) | Treatment of myopia | |
IL182436A0 (en) | Thienopyridinone compounds and methods of treatment | |
IL178815A0 (en) | The treatment of respiratory disease | |
EP1962869A4 (en) | Treatment of respiratory diseases | |
EP1778245A4 (en) | T type calcium channel blockers and the treatment of diseases | |
EP1968591A4 (en) | Treatment of synucleinopathies | |
GB0410399D0 (en) | The treatment of respiratory disease | |
ZA200610736B (en) | Treatment of hydrocarbons | |
IL178289A0 (en) | Treatment of impaired respiratory function with gaboxadol | |
GB0426196D0 (en) | Methods of treatment | |
GB0410502D0 (en) | Treatment of metakaolin | |
GB0625234D0 (en) | Treatment of Hydrocarbons | |
GB0423173D0 (en) | Treatment of diabetes | |
ZA200704046B (en) | Treatment of burns | |
GB0512646D0 (en) | Treatment of gases | |
GB2412585B (en) | Muscle treatment | |
EP1871404A4 (en) | Treatment of asthma | |
HU0400952D0 (en) | Treatment of anus-cancer | |
GB0423927D0 (en) | The treatment of IBD | |
GB0422012D0 (en) | Methods of treatment | |
GB0418125D0 (en) | Treatment of effluent gases | |
GB0423245D0 (en) | Treatment of breathing disorders | |
GB0414428D0 (en) | Compounds and methods of treatment |